{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:41:27Z","timestamp":1794048087546,"version":"4.8.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Emerg Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tizanidine, an \u03b1-2 adrenoceptor agonist, is widely prescribed for the management of spasticity in adults. Case reports on pediatric tizanidine overdose are limited. Here, we report a case of pediatric tizanidine toxicity that was reversed with naloxone.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 3-year-old male presented to the emergency department with lethargy, bradycardia, and bradypnea after accidental ingestion of multiple tizanidine tablets. Improvements in the level of consciousness and respiratory and heart rates were observed after two intravenous administrations of naloxone at a dose of 0.05 and 0.1 mg\/kg, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case report provides further evidence regarding the use of naloxone as a viable antidote for centrally acting \u03b1-2 receptor agonists and presents additional epidemiologic data on childhood tizanidine poisoning.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12245-021-00397-y","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T09:06:11Z","timestamp":1639472771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pediatric tizanidine toxicity reversed with naloxone: a case report"],"prefix":"10.1186","volume":"14","author":[{"given":"Doaa","family":"Bader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Shaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader","family":"Alyahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,14]]},"reference":[{"issue":"12","key":"397_CR1","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1517\/14656566.9.12.2209","volume":"9","author":"G Malanga","year":"2008","unstructured":"Malanga G, Reiter RD, Garay E. Update on tizanidine for muscle spasticity and emerging indications. Expert Opin Pharmacother. 2008;9(12):2209\u201315. https:\/\/doi.org\/10.1517\/14656566.9.12.2209.","journal-title":"Expert Opin Pharmacother"},{"issue":"1-2","key":"397_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1615\/CritRevPhysRehabilMed.2013007945","volume":"25","author":"E Chang","year":"2013","unstructured":"Chang E, Ghosh N, Yanni D, Lee S, Alexandru D, Mozaffar T. A review of spasticity treatments: pharmacological and interventional approaches. Crit Rev Phys Rehabil Med. 2013;25(1-2):11\u201322. https:\/\/doi.org\/10.1615\/CritRevPhysRehabilMed.2013007945.","journal-title":"Crit Rev Phys Rehabil Med"},{"issue":"2","key":"397_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1185\/030079908X261113","volume":"24","author":"L Kamen","year":"2008","unstructured":"Kamen L, Henney HR, Runyan JD. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury. Curr Med Res Opin. 2008;24(2):425\u201339. https:\/\/doi.org\/10.1185\/030079908X261113.","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"397_CR4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3109\/15563650.2014.898770","volume":"52","author":"JA Lowry","year":"2014","unstructured":"Lowry JA, Brown JT. Significance of the imidazoline receptors in toxicology. Clin Toxicol (Phila). 2014;52(5):454\u201369. https:\/\/doi.org\/10.3109\/15563650.2014.898770.","journal-title":"Clin Toxicol (Phila)"},{"issue":"5","key":"397_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1081\/CLT-200026978","volume":"42","author":"HA Spiller","year":"2004","unstructured":"Spiller HA, Bosse GM, Adamson LA. Retrospective review of tizanidine (zanaflex\u00ae) overdose. J Toxicol Clin Toxicol. 2004;42(5):593\u20136. https:\/\/doi.org\/10.1081\/CLT-200026978.","journal-title":"J Toxicol Clin Toxicol"},{"issue":"1","key":"397_CR6","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1097\/MJT.0b013e318293b0e8","volume":"22","author":"SA Ahmad","year":"2015","unstructured":"Ahmad SA, Scolnik D, Snehal V, Glatstein M. Use of naloxone for clonidine intoxication in the pediatric age group: case report and review of the literature. Am J Ther. 2015;22(1):e14\u20136. https:\/\/doi.org\/10.1097\/MJT.0b013e318293b0e8.","journal-title":"Am J Ther"},{"issue":"12","key":"397_CR7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/j.1440-1754.2004.00491.x","volume":"40","author":"Y Sinha","year":"2004","unstructured":"Sinha Y, Cranswick NE. Clonidine poisoning in children: a recent experience. J Paediatr Child Health. 2004;40(12):678\u201380. https:\/\/doi.org\/10.1111\/j.1440-1754.2004.00491.x.","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"397_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jpeds.2013.08.038","volume":"164","author":"GS Wang","year":"2014","unstructured":"Wang GS, Le Lait MC, Heard K. Unintentional pediatric exposures to central alpha-2 agonists reported to the national poison data system. J Pediatr. 2014;164(1):149\u201352. https:\/\/doi.org\/10.1016\/j.jpeds.2013.08.038.","journal-title":"J Pediatr"},{"issue":"3","key":"397_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0736-4679(03)00206-3","volume":"25","author":"O Eddy","year":"2003","unstructured":"Eddy O, Howell JM, Love JN. Are one or two dangerous? Clonidine and topical imidazolines exposure in toddlers. J Emerg Med. 2003;25(3):297\u2013302. https:\/\/doi.org\/10.1016\/S0736-4679(03)00206-3.","journal-title":"J Emerg Med"},{"issue":"4","key":"397_CR10","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.emc.2004.05.004","volume":"22","author":"JB Michael","year":"2004","unstructured":"Michael JB, Sztajnkrycer MD. Deadly pediatric poisons: nine common agents that kill at low doses. Emerg Med Clin North Am. 2004;22(4):1019\u201350. https:\/\/doi.org\/10.1016\/j.emc.2004.05.004.","journal-title":"Emerg Med Clin North Am"},{"issue":"3","key":"397_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00006565-199906000-00008","volume":"15","author":"JF Holmes","year":"1999","unstructured":"Holmes JF, Berman DA. Use of naloxpne to reverse symptomatic tetrahydrozoline overdose in a child. Pediatr Emerg Care. 1999;15(3):193\u20134. https:\/\/doi.org\/10.1097\/00006565-199906000-00008.","journal-title":"Pediatr Emerg Care"},{"issue":"3","key":"397_CR12","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1442-200X.2010.03040.x","volume":"52","author":"S Katar","year":"2010","unstructured":"Katar S, Taskesen M, Okur N. Naloxone use in a newborn with apnea due to tetrahydrozoline intoxication. Pediatr Int. 2010;52(3):488\u20139. https:\/\/doi.org\/10.1111\/j.1442-200X.2010.03040.x.","journal-title":"Pediatr Int"},{"issue":"2","key":"397_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jpeds.2004.09.027","volume":"146","author":"HA Spiller","year":"2005","unstructured":"Spiller HA, Klein-Schwartz W, Colvin JM, Villalobos D, Johnson PB, Anderson DL. Toxic clonidine ingestion in children. J Pediatr. 2005;146(2):263\u20136. https:\/\/doi.org\/10.1016\/j.jpeds.2004.09.027.","journal-title":"J Pediatr"},{"issue":"10","key":"397_CR14","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/PEC.0b013e31826ce9f1","volume":"28","author":"DS Tsze","year":"2012","unstructured":"Tsze DS, Dayan PS. Treatment of guanfacine toxicity with naloxone. Pediatr Emerg Care. 2012;28(10):1060\u20131. https:\/\/doi.org\/10.1097\/PEC.0b013e31826ce9f1.","journal-title":"Pediatr Emerg Care"},{"issue":"6","key":"397_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1046\/j.1440-1754.1998.00301.x","volume":"34","author":"C Kappagoda","year":"1998","unstructured":"Kappagoda C, Schell DN, Hanson RM, Hutchins P. Clonidine overdose in childhood: Implications of increased prescribing. J Paediatr Child Health. 1998;34(6):508\u201312. https:\/\/doi.org\/10.1046\/j.1440-1754.1998.00301.x.","journal-title":"J Paediatr Child Health"},{"issue":"12","key":"397_CR16","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/archpedi.1983.02140380030009","volume":"137","author":"W Banner","year":"1983","unstructured":"Banner W, Lund ME, Clawson L. Failure of naloxone to reverse clonidine toxic effect. Am J Dis Child. 1983;137(12):1170\u20131. https:\/\/doi.org\/10.1001\/archpedi.1983.02140380030009.","journal-title":"Am J Dis Child"}],"container-title":["International Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-021-00397-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12245-021-00397-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-021-00397-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T09:06:13Z","timestamp":1639472773000},"score":1,"resource":{"primary":{"URL":"https:\/\/intjem.biomedcentral.com\/articles\/10.1186\/s12245-021-00397-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["397"],"URL":"https:\/\/doi.org\/10.1186\/s12245-021-00397-y","relation":{},"ISSN":["1865-1372","1865-1380"],"issn-type":[{"value":"1865-1372","type":"print"},{"value":"1865-1380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"30 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee at the Royal Commission Medical Center, Yanbu, approved this case report for publication.Consent for publication of this case report was obtained from the patient\u2019s parents. This report does not contain any personal information that can lead to the identification of the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"An informed consent was obtained from the child\u2019s parents","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}